ZA922297B - Crystalline tiababine monohydrate,its preparation and use - Google Patents

Crystalline tiababine monohydrate,its preparation and use

Info

Publication number
ZA922297B
ZA922297B ZA922297A ZA922297A ZA922297B ZA 922297 B ZA922297 B ZA 922297B ZA 922297 A ZA922297 A ZA 922297A ZA 922297 A ZA922297 A ZA 922297A ZA 922297 B ZA922297 B ZA 922297B
Authority
ZA
South Africa
Prior art keywords
preparation
monohydrate
tiababine
crystalline
compositions containing
Prior art date
Application number
ZA922297A
Other languages
English (en)
Inventor
Henning Petersen
Petersen Henning
Peter Nielsen
Nielsen Peter
Michael Cain
Cain Michael
Subhash R Patel
R Patel Subhash
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of ZA922297B publication Critical patent/ZA922297B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
ZA922297A 1991-04-02 1992-03-30 Crystalline tiababine monohydrate,its preparation and use ZA922297B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK91582A DK58291D0 (da) 1991-04-02 1991-04-02 Krystalinsk stof og dets fremstilling

Publications (1)

Publication Number Publication Date
ZA922297B true ZA922297B (en) 1992-12-30

Family

ID=8095193

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA922297A ZA922297B (en) 1991-04-02 1992-03-30 Crystalline tiababine monohydrate,its preparation and use

Country Status (15)

Country Link
US (1) US5354760A (de)
EP (1) EP0579681B1 (de)
AT (1) ATE180781T1 (de)
AU (1) AU661483B2 (de)
CA (1) CA2107223C (de)
DE (1) DE69229339T2 (de)
DK (2) DK58291D0 (de)
ES (1) ES2134801T3 (de)
FI (1) FI110096B (de)
GR (1) GR3030919T3 (de)
IL (1) IL101358A (de)
NO (1) NO304113B1 (de)
NZ (1) NZ242191A (de)
WO (1) WO1992017473A1 (de)
ZA (1) ZA922297B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750140A (en) * 1994-05-20 1998-05-12 Novo Nordisk A/S Transdermal delivery of tiagabine
JP3195360B2 (ja) * 1995-05-05 2001-08-06 ノボ ノルディスク アクティーゼルスカブ チアガビン塩酸塩を含有する医薬組成物およびその製法
AU736514B2 (en) * 1995-07-13 2001-07-26 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Non-allosteric gabaa agonists for treating sleep disorders
DE19525598C2 (de) * 1995-07-13 1997-09-25 Max Planck Gesellschaft Schlafmittel
UA52661C2 (uk) * 1996-06-14 2003-01-15 Ново Нордіск А/С Безводна кристалічна форма гідрохлориду r(-)-n-(4,4-ди(3-метилтієн-2-іл)бут-3-еніл) ніпекотинової кислоти
US5914333A (en) * 1996-07-31 1999-06-22 Novo Nordisk A/S Treatment of psychotic disorders
IE970588A1 (en) 1997-08-01 2000-08-23 Elan Corp Plc Controlled release pharmaceutical compositions containing tiagabine
FR2771292B1 (fr) * 1997-11-21 2000-02-18 Ethypharm Lab Prod Ethiques Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
US6562974B2 (en) 2000-02-01 2003-05-13 The Procter & Gamble Company Process for making geminal bisphosphonates
US6410520B2 (en) 2000-02-01 2002-06-25 The Procter & Gamble Company Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate
EP2266590A3 (de) 2002-02-22 2011-04-20 Shire LLC Wirkstoff-Abgabesystem und Verfahren zum Schutz und zur Verabreichung von Wirkstoffen
CN1314684C (zh) * 2003-12-24 2007-05-09 中国科学院上海有机化学研究所 噻加宾及其消旋体和s－构型的合成方法及其无定形粉末的制法
US7667042B2 (en) * 2003-12-24 2010-02-23 Sun Pharma Advanced Research Company Ltd. Stable polymorphic forms of an anticonvulsant
WO2005092886A1 (en) * 2004-03-29 2005-10-06 Ranbaxy Laboratories Limited Process for the preparation of amorphous form of tiagabine
WO2006013550A2 (en) * 2004-08-04 2006-02-09 Ranbaxy Laboratories Limited Process for preparation of piperidine carboxylic acid
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US20080064727A1 (en) * 2006-08-18 2008-03-13 Cephalon, Inc. Crystalline forms of tiagabine hydrochloride
US20080051435A1 (en) * 2006-08-18 2008-02-28 Cephalon, Inc. Crystalline and amorphous forms of tiagabine
CN101857591B (zh) * 2009-04-09 2013-06-05 北京京卫燕康药物研究所有限公司 盐酸噻加宾晶型及其制备方法
CN103554093B (zh) * 2013-11-12 2015-10-21 四川科瑞德凯华制药有限公司 噻加宾乙酯盐酸盐及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
ES2058061T3 (es) * 1985-10-25 1994-11-01 Beecham Group Plc Derivado de piperidina, su preparacion y su uso como medicamento.
US4910312A (en) * 1985-11-08 1990-03-20 Warner-Lambert Company Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof

Also Published As

Publication number Publication date
DK0579681T3 (da) 1999-11-15
FI934298A (fi) 1993-09-30
DE69229339D1 (de) 1999-07-08
AU1641592A (en) 1992-11-02
CA2107223C (en) 2005-02-15
NO933524L (no) 1993-10-01
ES2134801T3 (es) 1999-10-16
FI110096B (fi) 2002-11-29
AU661483B2 (en) 1995-07-27
IL101358A (en) 1996-08-04
DK58291D0 (da) 1991-04-02
FI934298A0 (fi) 1993-09-30
IL101358A0 (en) 1992-11-15
ATE180781T1 (de) 1999-06-15
US5354760A (en) 1994-10-11
EP0579681A1 (de) 1994-01-26
JPH06506209A (ja) 1994-07-14
EP0579681B1 (de) 1999-06-02
NO933524D0 (no) 1993-10-01
NZ242191A (en) 1994-07-26
DE69229339T2 (de) 1999-12-30
CA2107223A1 (en) 1992-10-03
WO1992017473A1 (en) 1992-10-15
NO304113B1 (no) 1998-10-26
GR3030919T3 (en) 1999-11-30

Similar Documents

Publication Publication Date Title
ZA922297B (en) Crystalline tiababine monohydrate,its preparation and use
TW272195B (de)
IL127244A (en) Substituted amines, methods of their preparation and pharmaceutical compositions containing them
PT915898E (pt) Forma i cristalina de claritromicina
HUP9800417A3 (en) 5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)-indoles and 5-substituted-3-(piperidin-4-yl)-1h-indoles, their use as new 5-ht agonists, pharmaceutical compositions containing these compounds
IL97037A0 (en) Triazolopyridine containing compounds,process for the preparation thereof and herbicidal compositions containing the same
HRP20020330B1 (de)
WO1992019617A3 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
GB2234510A (en) Ethyl 6-bromo-5-hydroxy-4-dimethylaminomethyl-1-methyl-2-phenylthiomethylindole-3-carboxylate hydrochloride monohydrate, process for & compositions thereof
DE69907926D1 (de) 1,2,4-triazol-3-thion verbindungen
HU9401691D0 (en) 2-oximino-2-phenyl-acetamide derivatives, process for their preparation, their use and fungicidal compositions containing them
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
GB9907571D0 (en) Compounds
TW252979B (de)
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
IL109866A0 (en) Crystalline 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (+) l-hydrogentartrate, its preparation and pharmaceutical compositions containing it
TW218011B (de)
AP9901472A0 (en) Crystalline pharmaceutical product.
EP0316639A3 (en) Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient
TWI231815B (en) Glycopeptide derivatives and pharmaceutical compositions containing the same for use as antibacterial agents
AP9600780A0 (en) Process for the preparation of peroxetine hydrochloride anhydrate and its use as therapeutic agent.
HU910063D0 (en) Process for the production of preparations containing synergetic combination of active agents of natural origin, usable for selective decreasing of blood lipoids